Compare Stocks → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:HUGEOTCMKTS:OCQLFNASDAQ:SAAS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHUGEFSD Pharma$0.37$0.65$0.35▼$1.68$14.84M0.71355,112 shs103,916 shsOCQLF01 Communique Laboratory$0.04$0.05$0.05▼$0.22N/AN/A5,680 shs27 shsSAAS(SAAS)$0.01$0.00$7.15▼$13.99N/AN/A1.05 million shs200,000 shs5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHUGEFSD Pharma+0.54%-14.72%-40.91%-55.23%-71.60%OCQLF01 Communique Laboratory0.00%-17.26%-37.46%-36.61%-66.31%SAAS(SAAS)0.00%0.00%0.00%0.00%0.00%Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guideMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHUGEFSD PharmaN/AN/AN/AN/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHUGEFSD PharmaN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHUGEFSD PharmaN/AN/AN/AN/A$0.33 per shareN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHUGEFSD Pharma-$17.90M-$0.47N/A∞N/AN/A-112.38%-82.46%5/10/2024 (Estimated)OCQLF01 Communique LaboratoryN/AN/A0.00∞N/AN/AN/AN/AN/ASAAS(SAAS)N/AN/A0.00∞N/AN/AN/AN/AN/ALatest HUGE, SAAS, and OCQLF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023HUGEFSD PharmaN/A-$0.04-$0.04-$0.04N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHUGEFSD PharmaN/AN/AN/AN/AN/AOCQLF01 Communique LaboratoryN/AN/AN/AN/AN/ASAAS(SAAS)N/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHUGEFSD PharmaN/A2.432.43OCQLF01 Communique LaboratoryN/AN/AN/ASAAS(SAAS)N/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipHUGEFSD Pharma1.24%OCQLF01 Communique LaboratoryN/ASAAS(SAAS)93.53%Insider OwnershipCompanyInsider OwnershipHUGEFSD Pharma8.53%OCQLF01 Communique LaboratoryN/ASAAS(SAAS)6.30%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableHUGEFSD Pharma1740.12 million36.70 millionOptionableOCQLF01 Communique LaboratoryN/AN/AN/ANot OptionableSAAS(SAAS)N/AN/AN/ANot OptionableHUGE, SAAS, and OCQLF HeadlinesSourceHeadlineEmpowering Users: Embracing Product-Centric Strategies in SaaSdqindia.com - May 7 at 5:48 AMS|W: The SaaS Weekly – Is Bill Gates still the real brains behind Microsoft?betakit.com - May 7 at 5:48 AMEcho360 Acquires Inkling to Form Premier Global Education and Corporate Learning SaaS Enterprisefinance.yahoo.com - May 6 at 7:43 PMRiver SaaS Capital launches first-ever venture equity fund with $50 millioncrainscleveland.com - May 6 at 2:43 PMSaaS identity security strategies to prevent cyber risk in the workplacemsn.com - May 6 at 2:43 PMFinancy in cash call for workplace equality SaaS platformafr.com - May 6 at 4:38 AMIRIS Business Services Introduces "IRIS Myeinvois" SaaS Platform for Seamless e-Invoice Compliance in Malaysiafinance.yahoo.com - May 5 at 11:38 PMLive drupa Demonstrations of Cutting-Edge SaaS Platformpiworld.com - May 3 at 8:24 PMOne Bridge SaaS Insider Raised Their Stake In The Previous Yearfinance.yahoo.com - May 3 at 8:24 PMSaas Bahu Aur Flamingo Turns 1 | Homi Adjania On Show's First Anniversary: We Knew...filmibeat.com - May 3 at 10:21 AM'Saas, Bahu Aur Flamingo' turns one; Homi Adajania speaks about its 'unexpected’ successmsn.com - May 3 at 10:21 AMNew Guide Explains How to Eliminate the Risk of Shadow SaaS and Protect Corporate Datathehackernews.com - May 3 at 10:21 AMBuy Rating on Thryv Holdings: Strong SaaS Growth and Strategic Financial Restructuringmarkets.businessinsider.com - May 3 at 10:21 AMUnlocking productivity: The rise of QR-driven horizontal SaaS solutions for enterprisesindiantelevision.com - May 3 at 1:38 AMEcode Dash Expands its IT Services to the Middle East and Europe, Meeting Growing SaaS Market Demandsmsn.com - May 2 at 3:37 PMNew industry SaaS company CoCoCo launchesprintweek.com - May 2 at 3:37 PMYour AI-native startup ain't the same as a typical SaaS companynews.yahoo.com - May 2 at 3:37 PMShadow IT And Zombie Accounts: The Silent Saboteurs Of SaaS Securityforbes.com - May 2 at 3:37 PMGo High Level SaaS Pricing Models Launch to Boost Digital Marketing Agencies' Service Offeringsfinance.yahoo.com - May 2 at 8:17 AMKaiser may Steer $250m Funding in SaaS Co Innovaccereconomictimes.indiatimes.com - May 2 at 1:46 AMAuction.io Acquires SaaS Platform SimpleAuctionSite.comfinance.yahoo.com - May 1 at 3:45 PMSecuring SaaS Apps in the Era of Generative AIthehackernews.com - May 1 at 3:45 PMWhy Is SaaS Company Conduent Stock On Fire Today?msn.com - May 1 at 3:45 PMLogicalis Australia becomes a Commvault SaaS MSP, helping customers protect their data anywhereitwire.com - May 1 at 3:31 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsFSD PharmaNASDAQ:HUGEFSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.01 Communique LaboratoryOTCMKTS:OCQLF01 Communique Laboratory, Inc. develops and markets remote access solutions. The Company's solutions consist of I'm InTouch, I'm OnCall and I'm InTouch Meeting product lines, which provide users with the ability to conduct online meetings. 01 Communique Laboratory was founded on October 7, 1992 and is headquartered in Toronto, Canada.(SAAS)NASDAQ:SAASinContact, Inc. (inContact) is a provider of cloud contact center software solutions. The Company provides a range of cloud contact center call routing, self-service and agent optimization solutions. The Company operates through two business segments: Software and Network connectivity. inContact's Software segment includes the services related to the delivery of its cloud contact center software solutions. Its Network connectivity segment includes the voice and data long distance services provided to customers. It offers its products and services to its customers in approximately five vertical markets, such as customer services and sales business process outsourcers (BPOs), retail and direct response, healthcare providers, utilities, and state and local Government. It provides software, which includes Automatic call distributing, Computer telephony integration, Interactive voice response with speech recognition, Outbound dialer, Screen recording and Interactive reporting tool. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.